Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Short Interest Up 1,484.6% in April

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 515,000 shares, a growth of 1,484.6% from the March 31st total of 32,500 shares. Currently, 2.8% of the shares of the company are short sold. Based on an average daily volume of 214,100 shares, the short-interest ratio is currently 2.4 days.

Institutional Investors Weigh In On Monogram Orthopaedics

A hedge fund recently bought a new stake in Monogram Orthopaedics stock. New Harbor Financial Group LLC purchased a new stake in Monogram Orthopaedics, Inc. (NASDAQ:MGRM) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 29,348 shares of the company’s stock, valued at approximately $101,000. New Harbor Financial Group LLC owned 0.09% of Monogram Orthopaedics as of its most recent SEC filing. Institutional investors own 0.45% of the company’s stock.

Monogram Orthopaedics Stock Performance

NASDAQ:MGRM traded up $0.03 during mid-day trading on Thursday, hitting $2.36. The stock had a trading volume of 35,731 shares, compared to its average volume of 181,510. Monogram Orthopaedics has a twelve month low of $1.53 and a twelve month high of $48.99. The stock has a market cap of $74.65 million and a price-to-earnings ratio of -2.99. The company’s 50 day simple moving average is $2.50 and its 200 day simple moving average is $2.93.

Monogram Orthopaedics (NASDAQ:MGRM) last issued its earnings results on Friday, March 15th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.37 million for the quarter. As a group, equities analysts forecast that Monogram Orthopaedics will post -0.43 earnings per share for the current year.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.